Certara Products Archives

Case Study

Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software

In 2019, Prelude Therapeutics, a small cancer drug discovery company, implemented Certara’s GlobalSubmit submissions management…

CertaraMarch 2, 2021

Blog

Getting Gene Therapies to Patients

This blog discusses the challenges that drug developers face in getting patients access to cell…

CertaraFebruary 16, 2021

Case Study

Early Value Assessment in Gene Therapy Clinical Trial Design

A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…

CertaraFebruary 12, 2021

White Paper

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

CertaraFebruary 3, 2021

Brochure

BaseCase Interactive for Medical Affairs

CertaraJanuary 28, 2021

Brochure

BaseCase Market Access

CertaraNovember 30, 2020

Press Coverage

Getting Real with RWE

By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…

CertaraNovember 20, 2020

Case Study

Galderma Achieves FDA Approval of AKLIEF® (trifarotene)

In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…

CertaraNovember 9, 2020

White Paper

The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal

CertaraOctober 28, 2020

On-Demand Webinar

SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU

In this webinar, our experts provided an overview of the SNDS and the key working…

CertaraOctober 20, 2020

Certara Products

Prelude Therapeutics reduces their quality control (QC) process for regulatory submissions from hours to minutes with Certara’s GlobalSubmit eCTD Software

Getting Gene Therapies to Patients

Early Value Assessment in Gene Therapy Clinical Trial Design

Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines

BaseCase Interactive for Medical Affairs

BaseCase Market Access

Getting Real with RWE

Galderma Achieves FDA Approval of AKLIEF® (trifarotene)

The Effects of COVID-19 on Stakeholder Engagement & Value Communication: Preparing for the New Normal

SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU

Newsletter sign up

Quick links

Solutions

Contact